Estimating infectiousness throughout SARS-CoV-2 infection course.
Jones TC, Biele G, Mühlemann B, Veith T, Schneider J, Beheim-Schwarzbach J, Bleicker T, Tesch J, Schmidt ML, Sander LE, Kurth F, Menzel P, Schwarzer R, Zuchowski M, Hofmann J, Krumbholz A, Stein A, Edelmann A, Corman VM, Drosten C. · 2021
Read Estimating infectiousness throughout SARS-CoV-2 infection course. by Jones TC, Biele G, Mühlemann B, Veith T, Schneider J, Beheim-Schwarzbach J, Bleicker T, Tesch J, Schmidt ML, Sander LE, Kurth F, Menzel P, Schwarzer R, Zuchowski M, Hofmann J, Krumbholz A, Stein A, Edelmann A, Corman VM, Drosten C. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9267347.txt.
Introduction
Jones and co-authors estimate infectiousness across the full course of SARS-CoV-2 infection. They link viral load in patient samples with the chance of growing virus in cells. The data come mainly from Berlin, where about 400,000 people were tested from February 2020 to March 2021. About 6% tested positive, and 25,381 positives were studied in depth.
People became infectious within two days of infection. In hospital cases, peak viral load came one to three days before symptoms began. About 8% of positives had very high viral loads. Loads were about tenfold higher in people infected with the variant first found in the UK. Children had slightly lower loads than adults. Findings apply even to people with few or no symptoms.
Catalog record
| CREATOR | Jones TC, Biele G, Mühlemann B, Veith T, Schneider J, Beheim-Schwarzbach J, Bleicker T, Tesch J, Schmidt ML, Sander LE, Kurth F, Menzel P, Schwarzer R, Zuchowski M, Hofmann J, Krumbholz A, Stein A, Edelmann A, Corman VM, Drosten C. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 94 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Estimating infectiousness throughout SARS-CoV-2 infection course By Terry C Jones, Guido Biele, Barbara Mühlemann, Talitha Veith, Julia Schneider, Jörn Beheim-Schwarzbach, Tobias Bleicker, Julia Tesch, Marie Luisa Schmidt, Leif Erik Sander, Florian Kurth, Peter Menzel Published in: Science (New York, N.y.) DOI: 10.1126/science.abi5273 ABSTRACT Correlates of infectiousness The role that individuals with asymptomatic or mildly symptomatic severe acute respiratory syndrome coronavirus 2 have in transmission of the virus is not well understood. Jones et al. investigated viral load in patients, comparing those showing few, if any, symptoms with hospitalized cases. Approximately 400,000 individuals, mostly from Berlin, were tested from February 2020 to March 2021 and about 6% tested positive. Of the 25,381 positive subjects, about 8% showed very high viral loads. People became infectious within 2 days of infection, and in hospitalized individuals, about 4 days elapsed from the start of virus shedding to the time of peak viral load, which occurred 1 to 3 days before the onset of symptoms. Overall, viral load was highly variable, but was about 10-fold higher in persons infected with the B.1.1.7 variant. Children had slightly lower viral loads than adults, although this difference may not be clinically significant. Science, abi5273, this issue p. eabi5273 Respiratory disease transmission is highly context-dependent and difficult to quantify or predict at the individual level. This is especially the case when transmission from presymptomatic, asymptomatic, and mildly symptomatic (PAMS) subjects is frequent, as with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1–8). Transmission is therefore typically inferred from population-level information and summarized as a single overall average, known as the basic reproductive number, R0. Although R0 is an essential and critical parameter for understanding and managing population-level disease dynamics, it is a resultant, downstream characterization of transmission. With regard to SARS-CoV-2, many finer-grained upstream questions regarding infectiousness remain unresolved or unaddressed. Three categories of uncertainty are (i) differences in infectiousness among individuals or groups such as PAMS subjects, according to age, gender, vaccination status, etc.; (ii) timing and degree of peak infectiousness, timing of loss of infectiousness, rates of infectiousness increase and decrease, and how these relate to onset of symptoms (when present); and (iii) differences in infectiousness due to inherent properties of virus variants. These interrelated issues can all be addressed through the combined study of two clinical virological parameters: the viral load (viral RNA concentration) in patient samples, and virus isolation success in cell culture trials. Viral load and cell culture infectivity cannot be translated directly to in vivo infectiousness, and the impact of social context and behavior on transmission is very high; nonetheless, these quantifiable parameters can generally be expected to be those most closely associated with transmission likelihood. A strong relationship between SARS-CoV-2 viral load and transmission has been reported (9), comparing favorably with the situation with influenza virus, where the association is less clear (10, 11). The emergence of more transmissible SARS-CoV-2 variants, such as the B.1.1.7 lineage (UK Variant of Concern 202012/01), emphasizes the importance of correlates of shedding and transmission. The scarcity of viral load data in people with recent variants, and in PAMS subjects of all ages (12), is a blind spot of key importance because many outbreaks have clearly been triggered and fueled by these subjects (2, 13–17). Viral load data from PAMS cases are rarely available, greatly reducing the number of studies with information from both symptomatic and PAMS subjects and that span the course of infections (12, 18). Making matters worse, it is not possible to place positive reverse transcription polymerase chain reaction (RT-PCR) results from asymptomatic subjects in time relative to a nonexistent day of symptom onset, so these cases cannot be included in studies focused on incubation period. Additionally, viral load time courses relative to the day of symptom onset rely on patient recall, a suboptimal measure that is subject to human error and that overlooks infections from presymptomatic or asymptomatic contacts (12). An alternative and more fundamental parameter, the day of peak viral load, can be estimated from dated viral load time-series data, drawn from the entire period of viral load rise and fall and the full range of symptomatic statuses. To better understand SARS-CoV-2 infectiousness, we analyzed viral load, cell culture isolation, and genome sequencing data from a diagnostic laboratory in Berlin (Charité–Universitätsmedizin Berlin Institute of Virology and Labor Berlin). We first address a set of questions regarding infectiousness at the moment of disease detection, especially in PAMS subjects whose infections were detected at walk-in community test centers. Because these people are circulating in the general community before their infections are detected, and are healthy enough to present themselves at such centers, their prevalence and shedding are of key importance to the understanding and prevention of transmission. In addition to PAMS subjects, we consider the infectiousness suggested by first-positive tests from hospitalized patients, including differences according to age, virus variant, and gender. A further set of temporal questions are then addressed by studying how infectiousness changes during the infection course. Using viral load measurements from patients with at least three RT-PCR tests, we estimate the onset of infectious viral shedding, peak viral load, and the rates of viral load increase and decline. Knowledge of these parameters enables fundamental comparisons between groups of subjects and between virus strains, and highlights the misleading impression created by viral loads from first-positive RT-PCR tests if the time of testing in the infection course is not considered. STUDY COMPOSITION We examined 936,423 SARS-CoV-2 routine diagnostic RT-PCR results from 415,935 subjects aged 0 to 100 years from 24 February 2020 to 2 April 2021. Samples were collected at test centers and medical practices mostly in and around Berlin, Germany, and analyzed with LightCycler 480 and cobas 6800/8800 systems from Roche. Of all tested subjects, 25,381 (6.1%) had at least one positive RT-PCR test (Table 1). Positive subjects had a mean age of 51.7 years with high standard deviation (SD) of 22.7 years, and a mean of 4.5 RT-PCR tests (SD 5.7), of which 1.7 (SD 1.4) were positive. Of the positive subjects, 4344 had tests on at least 3 days (with at least two tests positive) and were included in a time-series analysis. [Table: Age stratification of first-positive RT-PCR tests and viral load for 25,381 positive cases.N, number of subjects with a positive test result; Pos. %, percentage of positive subjects; Load (SD), mean log10(viral load) and standard deviation; ≥3 tests, number of subjects with at least three RT-PCR test results, as used in the viral load time course analysis. Age ranges (in years) are open-closed intervals.] We divided the 25,381 positive subjects into three groups (Fig. 1). The Hospitalized group (9519 subjects, 37.5%) included all those who tested positive in an in-patient hospitalized context at any point in their infection. The PAMS group (6110 subjects, 24.1%) included people whose first positive sample was obtained in any of 24 Berlin COVID-19 walk-in community test centers, provided they were not in the Hospitalized category. The Other group (9752 subjects, 38.4%) included everyone not in the first two categories (table S1). As Fig. 1 shows, there were relatively low numbers of young subjects in all three groups, and very few elderly PAMS subjects. The validity of the PAMS classification is supported by